Dog /

Breed profile · FDA CVM July 2026 extract

Shepherd Dog - Australian adverse-event record

Adverse-event filings for Shepherd Dog - Australian (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#13 of 510
by report volume (all breeds)
16,274
FDA CVM reports on file
3.7%
death-coded share of reports
#192 of 275
by death-coded share (≥50 reports)

How the 16,274 reports break down

By recorded gender -- every report on file for Shepherd Dog - Australian, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 1,502 1,126.5 751 375.5 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Shepherd Dog - Australian drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Shepherd Dog - Australian ranks #13 of 510 by total reports (16,274) and #192 of 275 by death-coded share (3.7%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#13
This breed, reports of 510
#192
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Shepherd Dog - Australian has 16,274 reports now versus 15,976 in that prior snapshot: 298 more (1.9%).

Report change
+298
Death-coded reports
+10
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Shepherd Dog - Australian changes

Total Reports

16,274

Highest-reported breed

Deaths Reported

608

of 16,274 reports

Death-coded share of reports

3.7%

Below-median death-coded share

Avg Age at Report

4.5 yr

20.0 kg avg weight

Breed Safety Scorecard

C+ (60/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate B
3.7%

Share of reports coded as a fatality

Euthanasia rate B-
1.8%

Share of reports resulting in euthanasia

Full recovery rate B-
32.5%

Share of reports coded "Recovered/Normal"

5-year trend F
+30%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Shepherd Dog - Australian death-coded reports 3.7%
Cross-breed median

3.7% of 16,274 shepherd dog - australian reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Shepherd Dog - Australian's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

4% 30th percentile Higher share than 30% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Shepherd Dog - Australian 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Shepherd Dog - Australian among report-volume vs. death-rate peers

Every breed shown has at least 50 filed reports. Volume reflects how often a breed is reported, not how common it is; death rate is the share of a breed's own reports coded as a death outcome.

Source: FDA openFDA Animal & Veterinary Adverse Events database 2×2 strategic matrix plotting 30 entities by Total Reports (X) and Death Rate (%) (Y), with a crosshair dividing the plot into four quadrants. High volume, high death rateLow volume, high death rateHigh volume, low death rateLow volume, low death rate 020,00040,00060,00080,000100,000 0%5%10%15% Total Reports Death Rate (%) Shepherd Dog - Australian vs. all breeds, report volume and death-coded share Retriever - Labrador-93675, 3.7%Crossbred Canine/dog-70591, 3.2%Domestic Shorthair-65226, 7.2%Dog (unknown)-48820, 8.8%Retriever - Golden-35980, 3.7%Shepherd Dog - German-32220, 4.4%Chihuahua-31521, 4.2%Terrier - Yorkshire-24924, 3.7%Shih Tzu-24405, 3.6%Boxer (German Boxer)-19405, 4.4%Beagle-17970, 3.6%Pit Bull-17865, 3.1%Shepherd Dog - Australian-16274, 3.7%Terrier (unspecified)-14058, 3.1%Maltese-13940, 3.2%Dachshund (unspecified)-13512, 4.6%Cat (unknown)-13248, 9.3%Terrier - Jack Russell-10423, 3.7%Collie - Border-10130, 4.3%Siberian Husky-9811, 4.5%Domestic Longhair-9615, 7%Pug-9224, 5.2%Spitz - German Pomeranian-9086, 4.9%Terrier - Bull - American Pit-8769, 4.7%Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog)-7871, 3.6%Terrier - Boston-7737, 4.5%Spaniel - Cocker American-7640, 4%Domestic (unspecified)-7576, 13.4%Poodle (unspecified)-7534, 3.4%Schnauzer - Miniature-7513, 4.4%
Source: FDA openFDA Animal & Veterinary Adverse Events database
Average weight at time of report: 20.0 kg (44.1 lbs)

Top Reported Reactions

Vomiting 3,563
Lack of efficacy (endoparasite) - heartworm 1,239
Lethargy (see also Central nervous system depression in 'Neurological') 1,215
Emesis 1,198
Diarrhoea 1,189
Lack of efficacy (endoparasite) - hookworm 886
Seizure NOS 813
Lack of efficacy (ectoparasite) - flea 770
Lack of efficacy - NOS 657
INEFFECTIVE, HEARTWORM LARVAE 606
Lack of efficacy (ectoparasite) - tick NOS 522
Lack of efficacy (bacteria) - Borrelia 490
Lack of efficacy (endoparasite) - roundworm NOS 442
Anorexia 415
Ataxia 380

Most Referenced Drugs

Milbemycin Oxime + Spinosad 2,933
Ivermectin + Pyrantel As Pamoate Salt 1,817
Pyrantel Pamoate;Sarolaner 1,664
Afoxolaner 1,342
Milbemycin Oxime + Praziquantel 1,106
Moxidectin 1,006
Fluralaner 13.64% 12-Week Chew 708
Fluralaner Chew Tablets 620
Spinosad 596
Bedinvetmab 436
Carprofen 422
Sarolaner 414
Lotilaner 404
Oclacitinib Maleate 353
Milbemycin Oxime 234

Outcome Breakdown

Recovered/Normal
5,294 (33.8%)
Outcome Unknown
4,784 (30.6%)
Ongoing
4,483 (28.6%)
Recovered with Sequela
482 (3.1%)
Died
309 (2.0%)
Euthanized
299 (1.9%)

Gender Distribution

Female 8,084 (49.7%)
Male 7,854 (48.3%)
Unknown 283 (1.7%)
Mixed 53 (0.3%)

Reports by Year

Year Reports Trend
2010 354
2011 383
2012 747
2013 850
2014 847
2015 926
2016 913
2017 1,046
2018 1,007
2019 1,110
2020 1,191
2021 1,146
2022 1,220
2023 1,324
2024 1,502
2025 1,494
2026 214

Shepherd Dog - Australian: low death-coded share in the FDA CVM extract

Signature read: 16,274 reports place Shepherd Dog - Australian in the upper third of breed filing volume (#13 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Shepherd Dog - Australian sits at #13 of 510 by report volume among all breeds and #12 of 298 among dog breeds, with 16,274 reports and 608 (3.7%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #192 of 275. Mean age at report: 4.5 years, average weight 20.0 kg (44.1 lbs).

Top reported signs: Vomiting (3,563), Lack of efficacy (endoparasite) - heartworm (1,239), Lethargy (see also Central nervous system depression in 'Neurological') (1,215). Most-referenced drug: Milbemycin Oxime + Spinosad (2,933 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (1,817) and Pyrantel Pamoate;Sarolaner (1,664).

Outcome coding on 15,651 status-recorded reports is dominated by Recovered/Normal (33.8%). Annual submissions ranged 214-2,026 across 17 years on file.

Shepherd Dog - Australian Reporting Concentration Profile

Shepherd Dog - Australian is a high-volume FDA CVM cohort (16,274 reports) - enough filings to measure how concentrated the reaction and drug mix is, not just the headline totals. Across 20 named reaction terms in the stored top list, the leading three (Vomiting, Lack of efficacy (endoparasite) - heartworm, Lethargy (see also Central nervous system depression in 'Neurological')) account for 37.3% of listed reaction mentions. The Herfindahl index on that list is 0.088 (1.0 = a single reaction owns every mention; lower = a broader clinical mix).

On the drug side, 20 referenced products appear in the top list; the leading three (Milbemycin Oxime + Spinosad, Ivermectin + Pyrantel As Pamoate Salt, Pyrantel Pamoate;Sarolaner) cover 42.6% of those mentions. That multi-product footprint is the profile thin-report breeds cannot show - their pages stop at a short bar list because the sample cannot support a concentration read.

Outcome coding on 15,651 status-recorded filings splits roughly 3.9% severe (died or euthanized - 608 reports) versus 36.9% recovered or recovered-with-sequela (5,776). Read that split next to the 3.7% death-coded share above - both track reporting severity bias in a popular breed, not a proven mortality rate.

Peak filing year was 2024 (1,502 reports); the lightest year on file was 2026 (214). From 2024 to 2025, annual volume fell 0.5% (1,502 → 1,494). Year-to-year swings at this volume usually track product launches, owner awareness, and reporting campaigns more than sudden breed-health shocks.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Shepherd Dog - Australian drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (3.7% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (20.0 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Shepherd Dog - Australian?
There are 16,274 adverse event reports involving Shepherd Dog - Australian in the FDA database, of which 608 were death-coded (3.7% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Shepherd Dog - Australian ranks #13 of 510 by report volume among all breeds PlainBreed indexes (#12 of 298 among dog breeds).
Where does Shepherd Dog - Australian sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Shepherd Dog - Australian is #13 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #12 of 298. Among breeds with at least 50 reports, its death-coded share ranks #192 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Shepherd Dog - Australian?
The most commonly reported adverse reactions for Shepherd Dog - Australian are Vomiting (3,563 reports), Lack of efficacy (endoparasite) - heartworm (1,239 reports), Lethargy (see also Central nervous system depression in 'Neurological') (1,215 reports), Emesis (1,198 reports), Diarrhoea (1,189 reports).
What drugs are most frequently associated with Shepherd Dog - Australian adverse events?
The drugs most frequently referenced in Shepherd Dog - Australian adverse event reports are Milbemycin Oxime + Spinosad (2,933 reports), Ivermectin + Pyrantel As Pamoate Salt (1,817 reports), Pyrantel Pamoate;Sarolaner (1,664 reports), Afoxolaner (1,342 reports), Milbemycin Oxime + Praziquantel (1,106 reports).
What is the average age of Shepherd Dog - Australian in adverse event reports?
The average age of Shepherd Dog - Australian at the time of adverse event reports is 4.5 years, with an average weight of 20.0 kg (44.1 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Shepherd Dog - Australian (Dog), extract as of July 2026 extract. 16,274 reports · 608 death-coded (3.7% of reports, not a mortality rate) · #13 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →